Edwards Lifesciences Corporatio (EW)

Edwards Lifesciences Corporation (Healthcare) reports an AlphaScore of 62/100 as of 2026-10-11, receiving a grade of B and a Watch signal. The data presents a high gross margin of 78.01% and a conservative debt-to-equity ratio of 0.06. A primary strength is the steady revenue growth of 11.55%. A notable risk is the elevated trailing PE ratio of 50.72. Evidence is strictly limited to the provided metrics.

Written 11/10/2026, 00:32:17 UTC · Snapshot 11/10/2026